Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 419

1.

Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.

Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1335-42. doi: 10.1016/j.ijrobp.2008.07.034. Epub 2008 Oct 14.

PMID:
18922648
2.

Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.

Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):779-88. doi: 10.1016/j.ijrobp.2008.05.040. Epub 2008 Aug 15.

PMID:
18707819
3.

Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.

Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT, Au DK, Wu PM, Choy DT.

Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):281-9.

PMID:
8892450
4.

Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.

Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL.

Cancer. 2006 Feb 15;106(4):820-9.

5.

Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.

Lee AW, Ng WT, Hung WM, Choi CW, Tung R, Ling YH, Cheng PT, Yau TK, Chang AT, Leung SK, Lee MC, Bentzen SM.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1121-8. doi: 10.1016/j.ijrobp.2008.05.023. Epub 2008 Aug 23.

PMID:
18723296
6.

Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.

Petsuksiri J, Sermsree A, Thephamongkhol K, Keskool P, Thongyai K, Chansilpa Y, Pattaranutaporn P.

Radiat Oncol. 2011 Feb 20;6:19. doi: 10.1186/1748-717X-6-19.

7.

Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.

Wei Y, Zhou T, Zhu J, Zhang Y, Sun M, Ding X, Wang D, Li H, Li B.

Cell Biochem Biophys. 2014 Jul;69(3):433-7. doi: 10.1007/s12013-014-9814-x.

PMID:
24510513
8.

Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.

Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY.

J Clin Oncol. 2006 Apr 20;24(12):1904-9.

PMID:
16622266
9.

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.

Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, Guo Y, Lin AH, Zeng XF, Ma J.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1356-64. doi: 10.1016/j.ijrobp.2007.12.028. Epub 2008 May 9.

PMID:
18472356
10.

Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.

Oh YT, Kim CH, Choi JH, Kang SH, Chun M.

Radiother Oncol. 2004 Jul;72(1):79-82.

PMID:
15236878
11.

Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.

Fuchs S, Rödel C, Brunner T, Iro H, Niedobitek G, Sauer R, Grabenbauer GG.

Onkologie. 2003 Feb;26(1):12-8.

PMID:
12624512
12.

Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results.

Tan EH, Chua ET, Wee J, Tan T, Fong KW, Ang PT, Lee KS, Lee KM, Khoo-Tan HS, Leong SS, Ong YK, Foo KF, Sethi VK, Chua EJ.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):597-601.

PMID:
10524411
13.

Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.

Lee AW, Tung SY, Chan AT, Chappell R, Fu YT, Lu TX, Tan T, Chua DT, O'sullivan B, Xu SL, Pang ES, Sze WM, Leung TW, Kwan WH, Chan PT, Liu XF, Tan EH, Sham JS, Siu L, Lau WH.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):142-51.

PMID:
16904519
14.

Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.

Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L, Siu L, Sze WM, Leung TW, Sham JS, Ngan RK, Law SC, Yau TK, Au JS, O'Sullivan B, Pang ES, O SK, Au GK, Lau JT; Hong Kong Nasopharyngeal Cancer Study Group.

J Clin Oncol. 2005 Oct 1;23(28):6966-75.

PMID:
16192584
15.

Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.

Atasoy BM, Dane F, Yumuk PF, Akgün Z, Turhal NS, Abacioğlu U, Sengöz M.

J BUON. 2008 Jan-Mar;13(1):43-50.

PMID:
18404785
16.

High frequency hearing loss following treatment for nasopharyngeal carcinoma.

Sumitsawan Y, Vaseenon V, Hanprasertpong C, Roongrotwattanasiri K, Chitapanarux I, Isaradisaikul S.

J Med Assoc Thai. 2010 Mar;93(3):324-9.

PMID:
20420107
17.

Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study.

Ho WK, Wei WI, Kwong DL, Sham JS, Tai PT, Yuen AP, Au DK.

Head Neck. 1999 Sep;21(6):547-53.

PMID:
10449671
18.

Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation.

Lee AW, Yau TK, Wong DH, Chan EW, Yeung RM, Ng WT, Tong M, Soong IS, Sze WM.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1331-8. Epub 2005 Sep 19.

PMID:
16169677
19.

Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.

Rodríguez N, Algara M, Foro P, Lacruz M, Reig A, Membrive I, Lozano J, López JL, Quera J, Fernández-Velilla E, Sanz X.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):810-7. doi: 10.1016/j.ijrobp.2008.04.064. Epub 2008 Aug 26.

PMID:
18755556
20.

Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.

Lee CC, Chu ST, Chou P.

Auris Nasus Larynx. 2009 Dec;36(6):688-94. doi: 10.1016/j.anl.2009.03.009. Epub 2009 May 1.

PMID:
19410399

Supplemental Content

Support Center